Results 211 to 220 of about 681,627 (391)

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol‐Associated Cirrhosis

Alimentary Pharmacology &Therapeutics, EarlyView.
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo, Sepideh Mehravar, Ellen Choi, Ju Dong Yang, Hyun‐Seok Kim, Yun Wang, Aarshi Vipani, Hirsh D. Trivedi, Walid Ayoub, Parnian Naji, Alexander Kuo, Chun‐Ying Wu, Lorenzo Leggio, Juan Pablo Arab   +13 more
wiley   +1 more source

Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients: A Comparative Study

Medicine, 2001
V. Pintado, P. Martín-Rabadán, M. L. Rivera, S. Moreno, E. Bouza   +4 more
semanticscholar   +1 more source

Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D

Alimentary Pharmacology &Therapeutics, EarlyView.
Bulevirtide increases bile acid levels in most patients; however, changes in bile acids do not predict virological response or adverse events, nor do they reflect treatment adherence. After discontinuation of bulevirtide, bile acid levels rapidly decline.
Marlene Hintersteininger, Michael Schwarz, Philipp Schwabl, Lukas Hartl, Lorenz Balcar, Benedikt Silvester Hofer, Georg Kramer, Christian Sebesta, Paul Thöne, Patrik Attalla, Michael Gschwantler, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Mathias Jachs   +14 more
wiley   +1 more source

Implementation and acceptance of pharmacists' prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). [PDF]

Can Pharm J (Ott)
d'Entremont-Harris M, Ramsey TD, MacNabb K, Murphy A, Bishop A, Isenor JE, Kelly DV, Al Hamarneh YN, Lee M, Ferguson A, Furlotte K, Woodill L, Hatchette T, Wilby KJ.   +13 more
europepmc   +1 more source

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.

Journal of Infectious Diseases, 2002
P. Kaleebu, N. French, C. Mahé, D. Yirrell, C. Watera, F. Lyagoba, J. Nakiyingi, A. Rutebemberwa, D. Morgan, J. Weber, C. Gilks, J. Whitworth   +11 more
semanticscholar   +1 more source

Experimental model to study co-infection of human immunodeficiency virus-type 1 (HIV-1_IIIB) and influenza virus in cell culture [PDF]

, 2015
Радка Аргирова, R. Nenova, Dimitar Ivanov, Petya Genova-Kalоu, S. Raleva   +4 more
openalex   +1 more source

A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser, Martijn. A. Oude Voshaar, Reinier C. A. van Linschoten, Alexander G. L. Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K. Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C. Janneke van der Woude, R. L. West, D. van Noord   +12 more
wiley   +1 more source

Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association. [PDF]

Cureus
Rijal S, Joshi A, P K.
europepmc   +1 more source

Mineral and Bone Disorder in Patients Living with the Human Immunodeficiency Virus (HIV) on Hemodialysis: A Case Series

, 2023
Júlia Braga Vaz, José Edevanilson de Barros Gueiros, Luiz Alberto Soares de Araújo Coutinho, Eduarda Cerqueira Russo, Ana Paula Santana Gueiros   +4 more
openalex   +1 more source

Quality Care in Midwifery‐Led Birth Centers: Assessing the Disconnect Between Reimbursement and Perinatal Outcomes

Birth, EarlyView.
ABSTRACT Background Health care financing is thought to be a driver of health care quality. The purpose of this research was to analyze reimbursement for midwifery‐led US birth centers and to evaluate the association between reimbursement ratios and clinical outcomes.
Sarah Bradbury, Diana Jolles, Lauren Hoehn‐Velasco, Susan Stapleton, Kate Bauer, Jill Alliman, Jennifer Stapleton   +6 more
wiley   +1 more source